The priority sections of the 1st Meeting WG Biomed are supported by Skoltech CREI Center for Data-Intensive Biomedicine and Biotechnology – one of the leading Russian excellence centers in the field.
|Antimicrobal Resistance||Cognitive Disorders|
|Professor Konstantin Severinov, CREI Director||Professor Philipp Khaitovich|
|Section annotation||Section annotation|
|Antibiotic resistance is one of the greatest threats to our societies and health systems, and the number of antibiotic-resistant bacteria is growing at a disquieting rate. In February 2017 the World Health Organization (WHO) published a list of the most life-threatening multidrug-resistant bacteria to draw the attention to pathogens that are becoming a recurring deadly menace all over the world, and for which the developing of new antibiotics must be a paramount priority.||The development of novel diagnostic and person medicine tools and routines based on Biomedical Big Data is the fastest growing direction of clinical development for complex diseases, including common cognitive disorders. This growth is further linked to development of other Biomed directions, including precision medicine, telemedicine, drug development and testing automation, and so on.|
1. Coordination of efforts to support translational R&D that leads to new, next-generation antibiotics as well as rapid diagnostics kits.
2. To support theoretical and applied research to define better the origin, spread, evolution, and development of resistance and the role of the innate immune system.
1. Identification of focused efforts for specific data types and data type combinations acquired jointly by dedicated centers across BRICS countries with particular focus on common cognitive disorders.
2. Unification of data types and formats collected across BRICS countries with specific focus on clinical and biological data related to common cognitive disorders.